PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go:
Extended
investment:
£295,000
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go:
Extended
investment:
Withheld
Plerith works with high growth start-ups and scaling companies to plan for and deliver growth. The company asserts that it helps companies promote their business to potential funders, through its network of angel and venture capital investors depending on the stage and sector of the said business. Plerith is partnering with Newable and Bristol Private Equity Club to deliver the fund in the South West London (SWL) area and identify and invest in the most exciting high growth companies in the region. Plerith argues that its deep knowledge of fundraising, sales, strategy, finance and technology would help SWL businesses flourish. Plerith aims to provide investors access to the highest quality local companies in the SWL region.
days to go:
Stretch
investment:
Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go:
TBC
investment:
£127,001
Wriggle is a real-time marketplace which creates a list of amazing eat-out food & drinking establishments for its users. The users search and pay directly using its mobile application and head to their chosen establishments. It has a transactional platform in three cities and is currently generating over 20,000 transactions per month. In March 2019, Wriggle has witnessed a monthly revenue of 175K. Wriggle has also won the Sparkies Awards Best App (twice). With the proceeds, Wriggle is planning to launch in new cities in the UK, increase revenue in the existing cities, and grow its technological team.
days to go:
Expired
investment:
£940,290
West Berkshire Brewery (WBB) have been brewing cask ales and bottled beers since 1995 and have won more than 40 awards. WBB use locally sourced ingredients and are trying to make their business as sustainable as possible.
days to go:
Expired
investment:
£1,765,482
Emopwering people to improve their musculoskeletal health through exercise. TrackActive is a physical health app that assesses a person's conditions, health and habits and delivers a personalised programme consisting of advice and exercises that adapt as the person progresses. The app is developed using rehabilitative exercise data, clinical algorithms and AI. The app can be used by organisations to view anonymised information on the health of their employees or customers and is distributed via public health, corporate and insurance partners.
TrackActive will be monetised via the aforementioned partners, who will pay an ongoing monthly subscription from £25 per month. This figure may increase depending on the health practitioners using the service. TrackActive's content, such as articles, video and images, can also be licensed to partners. Funds will be allocated towards developing the product further, with the inclusion of an Android version, admin dashboards, evidence-based content and regular updates to the app.
days to go:
Expired
investment:
£253,598
Wonderland is a modern burger joint offering top-tier organic meat and distinctive vegan recipes, setting itself apart with the slogan "Meat Vs Plants." With a compact menu built for scalability, sustainable practices in packaging, bespoke branding, and an alcohol license serving beers and cocktails, it creates a unique dining experience.
days to go:
Expired
investment:
£349,428
Fiinu are building a new digital bank. They intend to distrupt the financial services industry, whilst helping customers improve their lives through better banking and a people before profit ethos. Their goal is for customers to be in better financial shape after they join Fiinu. Fiinu is currently undergoing the Bank of England authorisation.
days to go:
Expired
investment:
£563,099
Cyclr is a cloud-based software that allows the user to connect the apps that they already run their business on. This makes it simple to synchronise data with another system.
days to go:
Expired
investment:
£100,490
